Literature DB >> 10415392

Response of amygdalar norepinephrine to footshock and GABAergic drugs using in vivo microdialysis and HPLC.

T Hatfield1, C Spanis, J L McGaugh.   

Abstract

These studies used in vivo microdialysis and high-performance liquid chromatography (HPLC) to examine levels of norepinephrine (NE) within the amygdala in response to both footshock and GABAergic compounds. In Experiment 1, microdialysis probes were inserted into a previously implanted guide cannula aimed at the amygdala and the level of NE was examined in response to footshock. A 0.55 mA (2 s) footshock induced a significant increase in NE levels when the microdialysis probe was located within the amygdala; levels of NE did not differ from baseline in rats with microdialysis probes located outside the amygdala. Experiment 2 examined the effects of the GABAergic antagonist, picrotoxin, the GABAergic agonist, muscimol, and saline on NE levels in the amygdala. Rats treated systemically with picrotoxin showed a dramatic increase in levels of NE within the amygdala. In contrast, systemic injection of muscimol resulted in decreased levels of NE. These findings are consistent with the hypothesis that drugs that are capable of modulating memory do so by altering levels of NE within the amygdala. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415392     DOI: 10.1016/s0006-8993(99)01566-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

1.  Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation.

Authors:  Benno Roozendaal; Ray Lengvilas; James L McGaugh; Olivier Civelli; Rainer K Reinscheid
Journal:  Learn Mem       Date:  2007-01-03       Impact factor: 2.460

2.  Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation.

Authors:  Deanne M Buffalari; Anthony A Grace
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 3.  Drug enhancement of memory consolidation: historical perspective and neurobiological implications.

Authors:  James L McGaugh; Benno Roozendaal
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

4.  Making lasting memories: remembering the significant.

Authors:  James L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

5.  Anxiogenic Effects of Acute Injection of Sesame oil May be Mediated by β-1 Adrenoceptors in the Basolateral Amygdala.

Authors:  Mahnaz Kesmati; Maysam Mard-Soltani; Lotfolah Khajehpour
Journal:  Adv Pharm Bull       Date:  2013-12-23

6.  Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation.

Authors:  B Roozendaal; B T Nguyen; A E Power; J L McGaugh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  GABA(C) Receptors in the Lateral Amygdala: A Possible Novel Target for the Treatment of Fear and Anxiety Disorders?

Authors:  Catarina Cunha; Marie-H Monfils; Joseph E Ledoux
Journal:  Front Behav Neurosci       Date:  2010-03-12       Impact factor: 3.558

Review 8.  Emotional enhancement of memory: how norepinephrine enables synaptic plasticity.

Authors:  Keith Tully; Vadim Y Bolshakov
Journal:  Mol Brain       Date:  2010-05-13       Impact factor: 4.041

9.  Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions.

Authors:  Jayme R McReynolds; Kyle Donowho; Amin Abdi; James L McGaugh; Benno Roozendaal; Christa K McIntyre
Journal:  Neurobiol Learn Mem       Date:  2009-11-22       Impact factor: 2.877

10.  Norepinephrine homogeneously inhibits alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate- (AMPAR-) mediated currents in all layers of the temporal cortex of the rat.

Authors:  Lu Dinh; Tram Nguyen; Humberto Salgado; Marco Atzori
Journal:  Neurochem Res       Date:  2009-04-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.